221 related articles for article (PubMed ID: 29024942)
21. RacGAP1 expression, increasing tumor malignant potential, as a predictive biomarker for lymph node metastasis and poor prognosis in colorectal cancer.
Imaoka H; Toiyama Y; Saigusa S; Kawamura M; Kawamoto A; Okugawa Y; Hiro J; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
Carcinogenesis; 2015 Mar; 36(3):346-54. PubMed ID: 25568185
[TBL] [Abstract][Full Text] [Related]
22. Loss-of-function of MYO5B is the main cause of microvillus inclusion disease: 15 novel mutations and a CaCo-2 RNAi cell model.
Ruemmele FM; Müller T; Schiefermeier N; Ebner HL; Lechner S; Pfaller K; Thöni CE; Goulet O; Lacaille F; Schmitz J; Colomb V; Sauvat F; Revillon Y; Canioni D; Brousse N; de Saint-Basile G; Lefebvre J; Heinz-Erian P; Enninger A; Utermann G; Hess MW; Janecke AR; Huber LA
Hum Mutat; 2010 May; 31(5):544-51. PubMed ID: 20186687
[TBL] [Abstract][Full Text] [Related]
23. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
[TBL] [Abstract][Full Text] [Related]
24. MYO5B mutations cause cholestasis with normal serum gamma-glutamyl transferase activity in children without microvillous inclusion disease.
Gonzales E; Taylor SA; Davit-Spraul A; Thébaut A; Thomassin N; Guettier C; Whitington PF; Jacquemin E
Hepatology; 2017 Jan; 65(1):164-173. PubMed ID: 27532546
[TBL] [Abstract][Full Text] [Related]
25. MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease.
Girard M; Lacaille F; Verkarre V; Mategot R; Feldmann G; Grodet A; Sauvat F; Irtan S; Davit-Spraul A; Jacquemin E; Ruemmele F; Rainteau D; Goulet O; Colomb V; Chardot C; Henrion-Caude A; Debray D
Hepatology; 2014 Jul; 60(1):301-10. PubMed ID: 24375397
[TBL] [Abstract][Full Text] [Related]
26. Cargo-selective apical exocytosis in epithelial cells is conducted by Myo5B, Slp4a, Vamp7, and Syntaxin 3.
Vogel GF; Klee KM; Janecke AR; Müller T; Hess MW; Huber LA
J Cell Biol; 2015 Nov; 211(3):587-604. PubMed ID: 26553929
[TBL] [Abstract][Full Text] [Related]
27. Compound Heterozygous Myosin 5B (Myo5b) Mutation with Early Onset Progressive Cholestasis and No Intestinal Failure.
Vij M; Shah V
Fetal Pediatr Pathol; 2022 Oct; 41(5):811-817. PubMed ID: 34338607
[No Abstract] [Full Text] [Related]
28. A Molecular Mechanism Underlying Genotype-Specific Intrahepatic Cholestasis Resulting From MYO5B Mutations.
Overeem AW; Li Q; Qiu YL; Cartón-García F; Leng C; Klappe K; Dronkers J; Hsiao NH; Wang JS; Arango D; van Ijzendoorn SCD
Hepatology; 2020 Jul; 72(1):213-229. PubMed ID: 31750554
[TBL] [Abstract][Full Text] [Related]
29. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
[TBL] [Abstract][Full Text] [Related]
30. DNA Hypermethylation of SHISA3 in Colorectal Cancer: An Independent Predictor of Poor Prognosis.
Tsai MH; Chen WC; Yu SL; Chen CC; Jao TM; Huang CY; Tzeng ST; Yen SJ; Yang YC
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1481-9. PubMed ID: 25968618
[TBL] [Abstract][Full Text] [Related]
31. MYO5B Gene Mutations: A Not Negligible Cause of Intrahepatic Cholestasis of Infancy With Normal Gamma-Glutamyl Transferase Phenotype.
Matarazzo L; Bianco AM; Athanasakis E; Serveres M; Francalanci P; Cenacchi G; Maggiore G; D'Adamo AP
J Pediatr Gastroenterol Nutr; 2022 May; 74(5):e115-e121. PubMed ID: 35129155
[TBL] [Abstract][Full Text] [Related]
32. NKX6.1 hypermethylation predicts the outcome of stage II colorectal cancer patients undergoing chemotherapy.
Chang SY; Kuo CC; Wu CC; Hsiao CW; Hu JM; Hsu CH; Chou YC; Shih YL; Lin YW
Genes Chromosomes Cancer; 2018 May; 57(5):268-277. PubMed ID: 29363224
[TBL] [Abstract][Full Text] [Related]
33. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.
Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677
[TBL] [Abstract][Full Text] [Related]
34. miR-4775 promotes colorectal cancer invasion and metastasis via the Smad7/TGFβ-mediated epithelial to mesenchymal transition.
Zhao S; Sun H; Jiang W; Mi Y; Zhang D; Wen Y; Cheng D; Tang H; Wu S; Yu Y; Liu X; Cui W; Zhang M; Sun X; Zhou Z; Peng Z; Yan D
Mol Cancer; 2017 Jan; 16(1):12. PubMed ID: 28095858
[TBL] [Abstract][Full Text] [Related]
35. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
[TBL] [Abstract][Full Text] [Related]
36. Hypomethylation-associated up-regulation of TCF3 expression and recurrence in stage II and III colorectal cancer.
Li C; Cai S; Wang X; Jiang Z
PLoS One; 2014; 9(11):e112005. PubMed ID: 25375219
[TBL] [Abstract][Full Text] [Related]
37. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
38. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
39. Down-regulation of osteoprotegerin expression as a novel biomarker for colorectal carcinoma.
Kim HS; Yoon G; Do SI; Kim SJ; Kim YW
Oncotarget; 2016 Mar; 7(12):15187-99. PubMed ID: 26942563
[TBL] [Abstract][Full Text] [Related]
40. MYO5B mutations cause microvillus inclusion disease and disrupt epithelial cell polarity.
Müller T; Hess MW; Schiefermeier N; Pfaller K; Ebner HL; Heinz-Erian P; Ponstingl H; Partsch J; Röllinghoff B; Köhler H; Berger T; Lenhartz H; Schlenck B; Houwen RJ; Taylor CJ; Zoller H; Lechner S; Goulet O; Utermann G; Ruemmele FM; Huber LA; Janecke AR
Nat Genet; 2008 Oct; 40(10):1163-5. PubMed ID: 18724368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
